Evidence map›Paper›PMID 28067305›Full record

ArticleScientific reports2017

Gomisin N inhibits adipogenesis and prevents high-fat diet-induced obesity.

Min-Kyung Jang, Ye-Rang Yun, Ji-Hyun Kim, Mi-Hee Park, Myeong Ho Jung

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Epigenetics of Childhood Obesity.Hormone research in paediatrics · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. SFood science and biotechnology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Antileishmanial Activity of Lignans, Neolignans, and Other Plant Phenols.Progress in the chemistry of organic natural products · 2021
    Article
  15. Functional Characterization of Gomisin N in High-Fat-InducedInternational journal of molecular sciences · 2020
    Article
  16. Article
  17. Article
  18. Gomisin N fromInternational journal of molecular sciences · 2020
    Article
  19. Review
  20. Ergosterol Peroxide from the Medicinal MushroomInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Min-Kyung JangDivision of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University, Yangsan-si, Gyeongnam, South Korea.
Ye-Rang YunHealthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan-si, Gyeongnam, South Korea.
Ji-Hyun KimDivision of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University, Yangsan-si, Gyeongnam, South Korea.
Mi-Hee ParkHealthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan-si, Gyeongnam, South Korea.
Myeong Ho JungDivision of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University, Yangsan-si, Gyeongnam, South Korea.
Pusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gomisin N (GN) is a physiological lignan derived from Schisandra chinensis. In the present study, we investigated the inhibitory effects of GN on differentiation of 3T3-L1 preadipocytes and the anti-obesity effects of GN in high-fat diet (HFD)-induced obese mice. Incubation with GN significantly inhibited the differentiation of 3T3-L1 preadipocytes in a dose-dependent manner. This inhibitory effect primarily occurred at an early adipogenic stage through impairment of mitotic clonal expansion (MCE) caused by cell cycle arrest at the G1/S phase transition. GN inhibited the extracellular signal-regulated kinase and phosphoinositide 3-kinase/protein kinase B signaling in the MCE process and activated AMP-activated protein kinase. Furthermore, GN downregulated CCAT/enhancer-binding protein β (C/EBPβ) and histone H3K9 demethylase JMJD2B during early stages of adipogenesis, and therefore repressed the expression of C/EBPβ-targeted cell cycle genes. In addition, GN also repressed the expression of histone H3K4 methyltransferase MLL4 and reduced PPARγ expression. Moreover, GN effectively lowered the final body weight, adipose tissue mass, and reduced the serum levels of glucose, total triglyceride, and cholesterol in the HFD-induced obese mice. GN also markedly reduced hepatic triglyceride level induced by HFD. Collectively, these findings suggest that GN has potential as a novel agent for the prevention and treatment of obesity.

Indexed as

3T3-L1 CellsAdipocytesAdipogenesisAnimalsCCAAT-Enhancer-Binding Protein-betaClone CellsCyclin-Dependent Kinase 2Cyclin-Dependent Kinase 6CyclinsCyclooctanesDiet, High-FatDown-RegulationFatty LiverHistone-Lysine N-MethyltransferaseLignansMaleCCAAT-Enhancer-Binding Protein-betaCyclin-Dependent Kinase 2Cyclin-Dependent Kinase 6CyclinsCyclooctanesHistone-Lysine N-MethyltransferaseLignansMLL4 protein, mousePolycyclic CompoundsPPAR gammaschizandrin B

Identifiers

PMID28067305
PMCPMC5220372
OpenAlexW2571378738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.